ENTERA BIO LTD. (ENTX) Free cash flow 2020–2025
ENTERA BIO LTD. (ENTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.5MFY2025 · since FY2020: -$10.6M → -$7.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.5M | -9.6% |
| FY2024 | -$6.8M | +6.9% |
| FY2023 | -$7.3M | +41.6% |
| FY2022 | -$12.5M | -38.2% |
| FY2021 | -$9.1M | +14.4% |
| FY2020 | -$10.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENTX financial trends
ENTX RevenueENTX Net incomeENTX Net marginENTX Gross profitENTX Gross marginENTX Operating incomeENTX Operating marginENTX Operating cash flowENTX Capital expendituresENTX Return on equityENTX Stock buybacksENTX Dividends paidENTX Total assetsENTX Total liabilitiesENTX Shareholders’ equityENTX overview →